The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

German start-up ATABIS GMBH focuses on identifying antigens implicated in oncogenesis and testing them for their ability to mobilize cytotoxic T cells, using a technique known as reverse immunology.